Board-certified Oncologist

Dr. Sarah Charney


Play Video

My Commitment To You

To our veterinary colleagues, my commitment is to be available so you can get me on the phone to discuss a mutual case - or even a potential case- with respect and collaboration.

To pet owners, my commitment is to provide expert information about the cancer process and then give you a range of options, free of judgement, from aggressive cancer treatment to palliative options. And above all, I’m committed to doing what’s best for the patient: your beloved pet.

– Dr. Sarah Charney
Primary Vets: Download Dr. Sarah Charney's FLyer


Dr. Sarah Charney is a veterinary medical oncologist and radiation oncologist. She is a co-owner of Boundary Bay Veterinary Specialty Hospital. Dr. Charney is passionately committed to providing cancer care for both her animal patients and their families. Dr. Charney believes that quality of life is paramount and works to ensure that her patients live as long as possible while still enjoying life.

Dr. Sarah Charney’s primary areas of interest include researching new chemotherapeutics and using radiosurgery to increase efficacy and decrease side effects of radiation.

Dr. Charney enjoys gourmet cooking, reading, hiking, boating and most of all, spending time with her three daughters and her dogs Elvis and Charlie.

Dr. Charney enjoys being part of the extended Boundary Bay Veterinary Specialty Hospital veterinary family that includes clients, patients, referring veterinarians, and all those who care about animals as much as we do.


Board Certification
  • American College of Veterinary Internal Medicine (Oncology)
  • American College of Veterinary Radiology (Radiation Oncology)
  • University of Chicago, Bachelor of Arts in Biology
  • University of Illinois, Doctor of Veterinary Medicine
  • University of Missouri, Internship in Small Animal Medicine and Surgery
  • Animal Medical Center, Oncology Residency
  • Southwest Veterinary Oncology, Radiation Oncology Residency
  • University of Missouri Phi Zeta Award for Clinical Research by an Intern
  • Connie Leifer Award for Outstanding Resident Research
  • Veterinary Cancer Society
  • CyberKnife Society
  • College of Veterinarians of British Columbia
  • American Veterinary Medical Association
  • Canadian Veterinary Medical Association

Use of an image-guided robotic radiosurgery system for the treatment of canine nonlymphomatous nasal tumors.

Glasser SA, Charney S, Dervisis NG, Witten MR, Ettinger S, Berg J, Joseph R.

J Am Anim Hosp Assoc. 2014 Mar-Apr;50(2):96-104. doi: 10.5326/JAAHA-MS-6024. Epub 2014 Jan 20.

PMID: 24446402

Biological behavior of oral and perioral mast cell tumors in dogs: 44 cases (1996-2006).

Hillman LA, Garrett LD, de Lorimier LP, Charney SC, Borst LB, Fan TM.

J Am Vet Med Assoc. 2010 Oct 15;237(8):936-42. doi: 10.2460/javma.237.8.936.

PMID: 20946081

Evaluation of a head-repositioner and Z-plate system for improved accuracy of dose delivery.

Charney SC, Lutz WR, Klein MK, Jones PD.

Vet Radiol Ultrasound. 2009 May-Jun;50(3):323-9.

PMID: 19507401

Double-blind placebo-controlled trial of adjuvant pamidronate with palliative radiotherapy and intravenous doxorubicin for canine appendicular osteosarcoma bone pain.

Fan TM, Charney SC, de Lorimier LP, Garrett LD, Griffon DJ, Gordon-Evans WJ, Wypij JM.

J Vet Intern Med. 2009 Jan-Feb;23(1):152-60. doi: 10.1111/j.1939-1676.2008.0221.x.

PMID: 19175734

In vivo and in vitro efficacy of zoledronate for treating oral squamous cell carcinoma in cats.

Wypij JM, Fan TM, Fredrickson RL, Barger AM, de Lorimier LP, Charney SC.

J Vet Intern Med. 2008 Jan-Feb;22(1):158-63. doi: 10.1111/j.1939-1676.2007.0010.x.

PMID: 18289304

In vitro cyclooxygenase-2 protein expression and enzymatic activity in neoplastic cells.

Heller DA, Fan TM, de Lorimier LP, Charney SC, Barger AM, Tannehill-Gregg SH, Rosol TJ, Wallig MA.

J Vet Intern Med. 2007 Sep-Oct;21(5):1048-55.

PMID: 17939563

Single-agent pamidronate for palliative therapy of canine appendicular osteosarcoma bone pain.

Fan TM, de Lorimier LP, O’Dell-Anderson K, Lacoste HI, Charney SC.

J Vet Intern Med. 2007 May-Jun;21(3):431-9.

PMID: 17552447

Clinicopathological findings and results of bone marrow aspiration in dogs with cutaneous mast cell tumours: 157 cases (1999-2002).

Endicott MM, Charney SC, McKnight JA, Loar AS, Barger AM, Bergman PJ.

Vet Comp Oncol. 2007 Mar;5(1):31-7. doi: 10.1111/j.1476-5829.2006.00115.x.

PMID: 19754799

Urine N-telopeptide excretion in dogs with appendicular osteosarcoma.

Lacoste H, Fan TM, de Lorimier LP, Charney SC.

J Vet Intern Med. 2006 Mar-Apr;20(2):335-41.

PMID: 16594591

Association of argyrophilic nucleolar organizing regions, Ki-67, and proliferating cell nuclear antigen scores with histologic grade and survival in dogs with soft tissue sarcomas: 60 cases (1996-2002).

Ettinger SN, Scase TJ, Oberthaler KT, Craft DM, McKnight JA, Leibman NF, Charney SC, Bergman PJ.

J Am Vet Med Assoc. 2006 Apr 1;228(7):1053-62.

PMID: 16579784

Retrospective evaluation of adjunctive doxorubicin for the treatment of feline mammary gland adenocarcinoma: 67 cases.

Novosad CA, Bergman PJ, O’Brien MG, McKnight JA, Charney SC, Selting KA, Graham JC, Correa SS, Rosenberg MP, Gieger TL.

J Am Anim Hosp Assoc. 2006 Mar-Apr;42(2):110-20.

PMID: 16527911

Evaluation of intracavitary mitoxantrone and carboplatin for treatment of carcinomatosis, sarcomatosis and mesothelioma, with or without malignant effusions: A retrospective analysis of 12 cases (1997-2002)*.

Charney SC, Bergman PJ, McKnight JA, Farrelly J, Novosad CA, Leibman NF, Camps-Palau MA.

Vet Comp Oncol. 2005 Dec;3(4):171-81. doi: 10.1111/j.1476-5810.2005.00075.x.

PMID: 19754772

Assessment of corticosteroid-induced alkaline phosphatase as a prognostic indicator in canine lymphoma.

Wiedemann AL, Charney SC, Barger AM, Schaeffer DJ, Kitchell BE.

J Small Anim Pract. 2005 Apr;46(4):185-90.

PMID: 15835237

Evaluation of intravenous pamidronate administration in 33 cancer-bearing dogs with primary or secondary bone involvement.

Fan TM, de Lorimier LP, Charney SC, Hintermeister JG.

J Vet Intern Med. 2005 Jan-Feb;19(1):74-80.

PMID: 15715051

Risk factors for sterile hemorrhagic cystitis in dogs with lymphoma receiving cyclophosphamide with or without concurrent administration of furosemide: 216 cases (1990-1996).

Charney SC, Bergman PJ, Hohenhaus AE, McKnight JA.

J Am Vet Med Assoc. 2003 May 15;222(10):1388-93.

PMID: 12762384

Recent Invited Presentations
  • CyberKnife Radiosurgery in Dogs and Cats, Veterinary Cancer Society Annual Meeting
  • CyberKnife Radiosurgery for Brain Tumors, ACVIM Annual Forum
  • Advances in Radiation Therapy, ACVR Annual Meeting

What can we help you find?